Prestige Brands Holdings, Inc. Earnings Cheat Sheet: Full Steam Ahead

Prestige Brands Holdings, Inc. (NASDAQ:PBH) reported higher profit for the first quarter as revenue showed growth. Prestige Brands Holdings, Inc. sells well-recognized, brand name over-the-counter healthcare, household cleaning and personal care products in a global marketplace.

Investing Insights: Steve Jobs Prepares to Deliver a New Catalyst for Apple’s Stock >>

Prestige Brands Holdings Earnings Cheat Sheet for the First Quarter

Results: Net income for Prestige Brands Holdings, Inc. rose to $14.8 million (29 cents per share) vs. $9.6 million (19 cents per share) in the same quarter a year earlier. This marks a rise of 53.8% from the year earlier quarter.

Revenue: Rose 33.8% to $95.3 million from the year earlier quarter.

Actual vs. Wall St. Expectations: PBH reported adjusted net income of 23 cents per share. By that measure, the company fell in line with the mean estimate of 23 cents per share. Analysts were expecting revenue of $95.4 million.

Quoting Management: “Our solid performance this quarter reflects our continued focus on key strategic initiatives which position Prestige for long-term growth,” said Matthew M. Mannelly, President and CEO. “Our fiscal 2011 acquisitions of Blacksmith Brands and Dramamine are now fully integrated into the OTC segment of our business, and we are investing in, and executing against, building the equity of these important brands.”

Key Stats:

Revenue has now gone up for three straight quarters. In the fourth quarter of the last fiscal year, revenue rose 35% to $96.4 million while the figure rose 20.1% in the third quarter of the last fiscal year from the year earlier.

The company has now fallen in line with estimates for the past two quarters. It reported net income of 18 cents in the fourth quarter of the last fiscal year.

Net income has increased 19.2% year over year on average across the last five quarters. The biggest gain came in the fourth of the last fiscal year, when income climbed 95.1% from the year earlier quarter.

Competitors to Watch: The Procter & Gamble Co. (NYSE:PG), Johnson & Johnson (NYSE:JNJ), Merck & Co., Inc. (NYSE:MRK), Perrigo Company (NASDAQ:PRGO), Watson Pharmaceuticals, Inc. (NYSE:WPI), Hi-Tech Pharmacal Co. (NASDAQ:HITK), Allergan, Inc. (NYSE:AGN), GlaxoSmithKline plc (NYSE:GSK), and Akorn, Inc. (NASDAQ:AKRX).

Investing Insights: Steve Jobs Prepares to Deliver a New Catalyst for Apple’s Stock >>

(Source: Xignite Financials)

More from The Cheat Sheet